Table of Contents
ISRN Gastroenterology
Volume 2011, Article ID 402583, 9 pages
http://dx.doi.org/10.5402/2011/402583
Research Article

Anorectal Motility and Sensation Abnormalities and Its Correlation with Anorectal Symptoms in Patients with Systemic Sclerosis: A Preliminary Study

1Department of Neuroscience and Cell Biology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0655, USA
2Department of Internal Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0655, USA
3Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0655, USA

Received 8 March 2011; Accepted 19 April 2011

Academic Editor: A. Nakajima

Copyright © 2011 Hanaa S. Sallam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Cohen, I. Laufer, W. J. Snape, Y. F. Shiau, G. M. Levine, and S. Jimenez, “The gastrointestinal manifestations of scleroderma: pathogenesis and management,” Gastroenterology, vol. 79, no. 1, pp. 155–166, 1980. View at Google Scholar · View at Scopus
  2. T. Ponge and S. B. Des Varannes, “Digestive involvement of scleroderma,” Revue du Praticien, vol. 52, no. 17, pp. 1896–1900, 2002. View at Google Scholar · View at Scopus
  3. R. Domsic, K. Fasanella, and K. Bielefeldt, “Gastrointestinal manifestations of systemic sclerosis,” Digestive Diseases and Sciences, vol. 53, no. 5, pp. 1163–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. W. Sjogren, “Gastrointestinal features of scleroderma,” Current Opinion in Rheumatology, vol. 8, no. 6, pp. 569–575, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Lock, M. Zeuner, B. Lang, R. Hein, J. Schölmerich, and A. Holstege, “Anorectal function in systemic sclerosis: correlation with esophageal dysfunction?” Diseases of the Colon and Rectum, vol. 40, no. 11, pp. 1328–1335, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. K. R. Sridhar, R. C. Lange, L. Magyar, I. Soykan, and R. W. McCallum, “Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications,” Journal of Laboratory and Clinical Medicine, vol. 132, no. 6, pp. 541–546, 1998. View at Google Scholar · View at Scopus
  7. S. Weston, M. Thumshirn, J. Wiste, and M. Camilleri, “Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders,” American Journal of Gastroenterology, vol. 93, no. 7, pp. 1085–1089, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. R. W. Sjogren, “Gastrointestinal motility disorders in scleroderma,” Arthritis and Rheumatism, vol. 37, no. 9, pp. 1265–1282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Attar, “Digestive manifestations in systemic sclerosis,” Annales de Medecine Interne, vol. 153, no. 4, pp. 260–264, 2002. View at Google Scholar · View at Scopus
  10. I. Marie, “Gastrointestinal involvement in systemic sclerosis,” Presse Medicale, vol. 35, no. 12, pp. 1952–1965, 2006. View at Google Scholar · View at Scopus
  11. H. Sallam, T. A. McNearney, and J. D. Z. Chen, “Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma),” Alimentary Pharmacology and Therapeutics, vol. 23, no. 6, pp. 691–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. C. Kim, H. J. Park, S. K. Lee et al., “Anorectal dysfunction in systemic sclerosis,” Journal of Korean Medical Science, vol. 11, no. 3, pp. 244–249, 1996. View at Google Scholar · View at Scopus
  13. G. Lock, A. Holstege, B. Lang, and J. Schölmerich, “Gastrointestinal manifestations of progressive systemic sclerosis,” American Journal of Gastroenterology, vol. 92, no. 5, pp. 763–771, 1997. View at Google Scholar · View at Scopus
  14. I. Marie, H. Levesque, P. Ducrotté et al., “Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study,” Arthritis and Rheumatism, vol. 41, no. 10, pp. 1874–1883, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Massone, L. Milone, A. Parodi, N. Pandolfo, and A. Rebora, “Anorectal involvement is frequent in limited systemic sclerosis,” Acta Dermato-Venereologica, vol. 82, no. 6, pp. 446–448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. E. Wollaston, X. Xu, O. Tokumaru, J. D. Z. Chen, and T. A. McNearney, “Patients with systemic sclerosis have unique and persistent alterations in gastric myoelectrical activity with acupressure to Neiguan point PC6,” Journal of Rheumatology, vol. 32, no. 3, pp. 494–501, 2005. View at Google Scholar · View at Scopus
  17. H. Sallam, T. A. McNearney, D. Doshi, and J. D. Z. Chen, “Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients,” Digestive Diseases and Sciences, vol. 52, no. 5, pp. 1329–1337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. “Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee,” Arthritis & Rheumatism, vol. 23, pp. 581–590, 1980.
  19. T. A. Medsger, S. Bombardieri, L. Czirjak, R. Scorza, A. Della Rossa, and W. Bencivelli, “Assessment of disease severity and prognosis,” Clinical and Experimental Rheumatology, vol. 21, no. 3, pp. S42–S46, 2003. View at Google Scholar · View at Scopus
  20. T. A. Medsger Jr., A. J. Silman, V. D. Steen et al., “A disease severity scale for systemic sclerosis: Development and testing,” Journal of Rheumatology, vol. 26, no. 10, pp. 2159–2167, 1999. View at Google Scholar · View at Scopus
  21. X. Xu, P. J. Pasricha, H. S. Sallam, L. Ma, and J. D. Z. Chen, “Clinical significance of quantitative assessment of rectoanal inhibitory reflex (RAIR) in patients with constipation,” Journal of Clinical Gastroenterology, vol. 42, no. 6, pp. 692–698, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. W. E. Whitehead, M. Delvaux, F. Azpiroz et al., “Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract,” Digestive Diseases and Sciences, vol. 42, no. 2, pp. 223–241, 1997. View at Publisher · View at Google Scholar
  23. S. S. C. Rao, R. Hatfield, E. Soffer, S. Rao, J. Beaty, and J. L. Conklin, “Manometric tests of anorectal function in healthy adults,” American Journal of Gastroenterology, vol. 94, no. 3, pp. 773–783, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Leighton, M. A. Valdovinos, J. H. Pemberton, D. M. Rath, and M. Camilleri, “Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis,” Diseases of the Colon and Rectum, vol. 36, no. 2, pp. 182–185, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Cossutta, S. Zeni, A. Soldi, P. Colombelli, A. Belotti Masserini, and F. Fantini, “Evaluation of quality of life in patients with systemic sclerosis by administering the SF-36 questionnaire,” Reumatismo, vol. 54, no. 2, pp. 122–127, 2002. View at Google Scholar · View at Scopus
  26. E. Danieli, P. Airò, L. Bettoni et al., “Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms,” Clinical Rheumatology, vol. 24, no. 1, pp. 48–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Del Rosso, M. Boldrini, D. D'Agostino et al., “Health-related quality of life in systemic sclerosis as measured by the short form 36: relationship with clinical and biologic markers,” Arthritis Care and Research, vol. 51, no. 3, pp. 475–481, 2004. View at Google Scholar · View at Scopus
  28. D. Khanna, R. D. Hays, G. S. Park et al., “Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument,” Arthritis Care and Research, vol. 57, no. 7, pp. 1280–1286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Najafi, M. Sheikhvatan, A. Montazeri, and M. Sheikhfathollahi, “Reliability of world health organization's quality of life-BREF versus short form 36 health survey questionnaires for assessment of quality of life in patients with coronary artery disease,” Journal of Cardiovascular Medicine, vol. 10, no. 4, pp. 316–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Lembo, B. Naliboff, J. Munakata, and S. Fullerton, “Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome,” American Journal of Gastroenterology, vol. 94, no. 5, pp. 1320–1326, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Groll, S. J. Vanner, W. T. Depew et al., “The IBS-36: a new quality of life measure for irritable bowel syndrome,” American Journal of Gastroenterology, vol. 97, no. 4, pp. 962–971, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. McNearney, X. Lin, J. Shrestha, J. Lisse, and J. D. Z. Chen, “Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography,” Digestive Diseases and Sciences, vol. 47, no. 4, pp. 690–698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. T. A. McNearney, H. S. Sallam, S. E. Hunnicutt et al., “Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients,” Neurogastroenterology and Motility, vol. 21, no. 12, pp. 1269–e120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. W. E. Whitehead, G. Taitelbaum, F. M. Wigley, and M. M. Schuster, “Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis,” Gastroenterology, vol. 96, no. 2 I, pp. 428–432, 1989. View at Google Scholar · View at Scopus
  35. G. J. Heyt, M. K. Oh, N. Alemzadeh et al., “Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence,” Digestive Diseases and Sciences, vol. 49, no. 6, pp. 1040–1045, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Basilisco, R. Barbera, M. Vanoli, and P. Bianchi, “Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis,” Digestive Diseases and Sciences, vol. 38, no. 8, pp. 1525–1529, 1993. View at Google Scholar · View at Scopus
  37. E. C. Ebert, “Gastric and enteric involvement in progressive systemic sclerosis,” Journal of Clinical Gastroenterology, vol. 42, no. 1, pp. 5–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. V. D. Steen and T. A. Medsger, “Severe organ involvement in systemic sclerosis with diffuse scleroderma,” Arthritis and Rheumatism, vol. 43, no. 11, pp. 2437–2444, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. P. H. Dessein, B. I. Joffe, R. M. Metz, D. L. Millar, M. Lawson, and A. E. Stanwix, “Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability,” American Journal of Medicine, vol. 93, no. 2, pp. 143–150, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Franck-Larsson, H. Hedenström, R. Dahl, and A. Rönnblom, “Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity,” Scandinavian Journal of Rheumatology, vol. 32, no. 6, pp. 348–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. S. Klimiuk, L. Taylor, R. D. Baker, and M. I. V. Jayson, “Autonomic neuropathy in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 47, no. 7, pp. 542–545, 1988. View at Google Scholar · View at Scopus
  42. C. Sonnex, E. Paice, and A. G. White, “Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients,” Annals of the Rheumatic Diseases, vol. 45, no. 11, pp. 957–960, 1986. View at Google Scholar · View at Scopus
  43. A. W. Chiou, J. K. Lin, and F. M. Wang, “Anorectal abnormalities in progressive systemic sclerosis,” Diseases of the Colon and Rectum, vol. 32, no. 5, pp. 417–421, 1989. View at Google Scholar · View at Scopus
  44. J. Hamel-Roy, G. Devroede, and P. Arhan, “Comparative esophageal and anorectal motility in scleroderma,” Gastroenterology, vol. 88, no. 1 I, pp. 1–7, 1985. View at Google Scholar
  45. B. W. Jaffin, P. Chang, and H. Spiera, “Fecal incontinence in scleroderma: clinical features, anorectal manometric findings, and their therapeutic implications,” Journal of Clinical Gastroenterology, vol. 25, no. 3, pp. 513–517, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Frieling, P. Enck, G. Bremer, H. J. Lubke, W. Berges, and M. Wienbeck, “Anorectal motility in systemic sclerosis,” Zeitschrift fur Gastroenterologie, vol. 26, no. 11, pp. 689–693, 1988. View at Google Scholar · View at Scopus
  47. A. J. DiMarino, G. Carlson, and A. Myers, “Duodenal myoelectric activity in scleroderma. Abnormal responses to mechanical and hormonal stimuli,” New England Journal of Medicine, vol. 289, no. 23, pp. 1220–1223, 1973. View at Google Scholar · View at Scopus
  48. G. D'Angelo, H. S. Stern, and E. Myers, “Rectal prolapse in scleroderma: case report and review of the colonic complications of scleroderma,” Canadian Journal of Surgery, vol. 28, no. 1, pp. 62–63, 1985. View at Google Scholar · View at Scopus
  49. A. L. Herrick, J. D. Barlow, A. Bowden et al., “Investigation of anal function in patients with systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 55, no. 6, pp. 370–374, 1996. View at Google Scholar · View at Scopus
  50. S. J. Wang, J. L. Lan, J. L. Lan et al., “Effects of cisapride on colonic transit in patients with progressive systemic sclerosis,” Clinical Rheumatology, vol. 21, no. 4, pp. 271–274, 2002. View at Publisher · View at Google Scholar · View at Scopus